FDA Approves Tecvayli (teclistamab-cqyv) for Relapsed or Refractory Multiple Myeloma (https://www.myeloma.org/fda-approves-tecvayli-teclistamab-cqyv-relapsed-or-refractory-multiple-myeloma)